New Mountain Finance Corporation is a closed end non diversified management investment company that was originally incorporated on June twenty nine twenty ten and completed its initial public offering on May nineteen twenty eleven. The company has elected to be regulated as a business development company under the Investment Company Act of nineteen forty. It also intends to maintain qualification as a regulated investment company under Subchapter M of the Internal Revenue…
New Mountain Finance Corporation is a closed end non diversified management investment company that was originally incorporated on June twenty nine twenty ten and completed its initial public offering on May nineteen twenty eleven. The company has elected to be regulated as a business development company under the Investment Company Act of nineteen forty. It also intends to maintain qualification as a regulated investment company under Subchapter M of the Internal Revenue Code. Since its IPO New Mountain Finance Corporation has raised approximately one billion thirty four point six million dollars in net proceeds from additional offerings of common stock. The firm is externally managed by New Mountain Finance Advisers L L C a wholly owned subsidiary of New Mountain Capital Group L P. New Mountain Capital is a global investment firm with about sixty billion dollars of assets under management and a track record of investing in the middle market. New Mountain Finance Corporation focuses its activities on providing direct lending solutions to US upper middle market companies that are backed by private equity sponsors. Its investment objective is to generate current income and capital appreciation through the sourcing and origination of senior secured loans and select junior capital positions. The firm leverages the sector expertise and operating resources of its affiliate New Mountain Capital to identify opportunities in defensive growth industries.
New Mountain Finance Corporation generates revenue primarily from interest income on its debt investments, dividend income on equity holdings and various fees related to loan origination, structuring, consulting and commitment activities. The company also realizes capital gains when it exits successful investments through sales or recapitalizations of portfolio companies. In addition to cash interest, the firm may receive payment in kind interest which is added to the principal balance and paid at maturity. The investment adviser earns a base management fee calculated as a percentage of gross assets and an incentive fee based on pre incentive net investment income and realized capital gains. As of December 31 2025 the weighted average yield to maturity at cost for income producing investments was approximately ten point five percent while the weighted average yield to maturity at cost for all investments was approximately nine point six percent. These returns reflect the company’s focus on senior secured loans and unitranche structures that offer attractive risk adjusted yields. The typical borrower is a US middle market company with annual earnings before interest taxes depreciation and amortization between ten million and two hundred million dollars. These companies are often sponsored by private equity firms and exhibit characteristics such as recurring revenue, strong free cash flow and niche market dominance.
New Mountain Finance Corporation operates in a competitive landscape that includes other business development companies, private equity funds, hedge funds and commercial banks that also extend credit to middle market enterprises. Many of these competitors possess greater financial resources and broader distribution networks. The company differentiates itself through the depth of experience of its management team, which includes seasoned professionals from New Mountain Capital and its investment committee. Its investment process benefits from close ties to New Mountain Capital’s sector analysts and operating partners, enabling rapid due diligence and informed structuring of transactions. The firm emphasizes defensive growth businesses that show acyclicality, sustainable secular growth drivers, high barriers to entry and resilient cash flow profiles. This focus allows New Mountain Finance Corporation to offer customized loan terms while maintaining disciplined underwriting standards. The company’s competitive advantages also stem from its ability to source investments through the proprietary deal flow of New Mountain Capital and its long standing relationships with private equity sponsors. Furthermore, the firm’s investment committee, composed of senior executives from the sponsor group, provides oversight and approval for larger transactions, ensuring consistency with the stated investment philosophy.
New Mountain Finance Corporation serves a diverse set of portfolio companies that represent its borrowers and equity investees. As of December 31 2025 the ten largest investments by fair value included NMFC Senior Loan Program III LLC, New Benevis Topco LLC New Benevis Holdco Inc, NMFC Senior Loan Program IV LLC, NM NL Holdings LP NM GP Holdco LLC, Dealer Tire Holdings LLC, Paw Midco Inc AAH Topco LLC, UniTek Global Services Inc, New Permian Holdco Inc New Permian Holdco LLC, Associations Inc and GC Waves Holdings Inc. These borrowers span sectors such as software, business services, healthcare, investment funds, consumer services, financial services technology, distribution and logistics, education, net lease and packaging. The company’s customer base consists primarily of privately held middle market enterprises that seek flexible financing solutions to support growth, acquisitions or recapitalizations. In addition to the top ten holdings, the firm held positions in one hundred thirteen portfolio companies at the end of 2025, reflecting a broad diversification across industries while maintaining a concentration in its core defensive sectors. The firm’s exposure to software and business services together accounted for more than thirty five percent of its total assets, underscoring its focus on technology enabled and outsourcing models. Healthcare and consumer services also contributed meaningfully to the portfolio, providing additional sources of stable cash flow. Overall, New Mountain Finance Corporation’s clientele comprises established businesses that demonstrate predictable revenue streams, capable management teams and the ability to generate attractive risk adjusted returns for its investors.
Sector:Financial ServicesSector rationaleThe company is a Business Development Company (BDC) that generates revenue primarily from interest income on senior secured loans and dividend income from equity holdings in middle-market companies. Its core business is providing direct lending solutions and managing a portfolio of debt and equity investments, which falls squarely under Specialty Finance within the Financial Services sector.Industries:Business Development CompaniesFinancial ServicesPrimaryThe company explicitly states it has elected to be regulated as a business development company (BDC) under the Investment Company Act of 1940. Its revenue is generated from interest income on senior secured loans and dividend income from equity holdings in US upper middle market companies.Alternative Asset ManagersFinancial ServicesSecondaryThe company is externally managed by New Mountain Finance Advisers LLC, a subsidiary of New Mountain Capital Group LP, which is described as a global investment firm managing approximately sixty billion dollars of assets in middle market private equity and credit strategies.Classified using BQ-MICSCIK: 0001496099
Investment Thesis
▲ Bull case
New Mountain Finance Corporation (NMFC) demonstrates significant upside potential through its aggressive share repurchase program and the strategic deployment of capital from the $470 million portfolio sale completed in Q1 FY26. Management explicitly stated that the company bought back shares at approximately $8 per share, representing a 27% discount to book value, with $57 million executed by March 31 and an additional $9 million thereafter, leaving $30 million in the original authorization. Furthermore, the Board authorized an incremental $50 million for buybacks, bringing total remaining capacity to around $80 million. Every $10 million of buyback at $8 per share adds approximately $0.04 per share to book value, creating a direct and measurable accretive effect. This activity is particularly compelling given that book value per share was $10.92 on March 31 and is $10.95 pro forma for post-March buybacks, indicating that the repurchases are already enhancing intrinsic value. The market appears to be undervaluing NMFC’s ability to consistently generate accretive returns through disciplined capital allocation, especially as the company leverages its balance sheet strength to buy back stock at deep discounts while maintaining ample liquidity for opportunistic investments. The combination of reduced share count and rising book value per share supports a sustainable path to NAV accretion that is not fully reflected in the current stock price.
NMFC’s investment in distressed or misunderstood assets presents a powerful, underappreciated catalyst for future NAV growth, particularly through secondary market purchases and turnaround opportunities in legacy equity holdings. During Q1 FY26, the company acquired a loan in a multibillion-dollar public company at just 2x EBITDA and $0.65 on the dollar, which rapidly traded up approximately 10 points post-purchase, demonstrating the efficacy of its contrarian approach. Management highlighted similar opportunities in the secondary market where they believe they have a “differentiated view” and the potential for “meaningful book value upside if our thesis proves correct.” Additionally, NMFC holds equity positions in companies like Benevis, UniTek, and Permian that have faced past challenges but are now showing forward momentum. UniTek, in particular, is positioned to benefit from the broadband build-out and data center expansion, with a backlog of projects tied to both public and private funding. Benevis, a dental business, has seen improving operational metrics under new leadership and is expected to come off nonaccrual as its capital structure is restructured. These assets are not merely being held for recovery; they are active sources of future upside through either improved operating performance or strategic monetization in a strengthening M&A environment. The market may be underestimating the probability and timing of these equity stakes transitioning from non-income-producing to value-generating assets, especially as NMFC plans to redeploy proceeds into higher-yielding, cash-producing loans.
The company’s evolving liability structure and asset mix position it to benefit disproportionately from a widening spread environment and rising interest rates, creating a structural tailwind that is not yet priced into the stock. As of March 31, NMFC’s loan portfolio was 89% floating rate, while liabilities were 73% floating rate, with the company actively working to match these percentages to reduce interest rate sensitivity. Management noted that the shift from 50% floating rate liabilities a year ago to the current 73% has already alleviated pressure from potential base rate decreases, and the ongoing evolution of this mix will further stabilize earnings in a volatile rate environment. More importantly, the CFO and COO indicated that general market spreads have widened by 25 to 50 basis points, with even broader widening in the software sector, allowing NMFC to deploy capital into new loans at significantly higher and more attractive yields than existed 12 months ago. The portfolio yield increased to 11.1% in Q1 FY26, driven by higher-yielding originations and the repositioning of the portfolio toward assets with better risk-adjusted returns. This shift is not temporary; it reflects a deliberate strategy to capitalize on market dislocations, and as spreads remain wide or widen further, NMFC’s net interest margin is poised to expand, directly boosting net investment income and dividend coverage. The market may be overlooking the durability of this earnings tailwind, assuming it is cyclical when in fact it is driven by structural changes in the company’s asset and liability composition.
NMFC’s disciplined risk management and improving credit metrics offer a foundation for stable, growing income that contrasts with market perceptions of heightened risk in the BDC sector. Despite broader market volatility, 91% of the portfolio remains rated green on the internal risk scale, with orange and red-rated assets constituting only 3.5% of fair value. Nonaccruals at fair value stood at 2.6% for the quarter, a modest increase, and management emphasized that the primary driver of NAV decline was broader market movement (accounting for two-thirds of the decline), not credit deterioration. Specific challenged names like Affordable Care and Convey are expected to exit nonaccrual status in coming quarters due to active restructuring efforts, including a change in control for Affordable Care that will reduce its debt burden and increase financial flexibility. The company has a track record of reversing unrealized losses, having realized only $56 million in net losses over approximately $10.5 billion of investments since its IPO. Furthermore, 98% of investment income is recurring, and 83% is paid in cash, underscoring the quality and sustainability of earnings. The market may be conflating NMFC with higher-risk peers in the private credit space, failing to recognize its conservative underwriting, low loss history, and proactive management of problem assets—factors that support a more resilient and predictable income stream than currently assumed.
New Mountain Finance Corporation (NMFC) demonstrates significant upside potential through its aggressive share repurchase program and the strategic deployment of capital from the $470 million portfolio sale completed in Q1 FY26. Management explicitly stated that the company bought back shares at approximately $8 per share, representing a 27% discount to book value, with $57 million executed by March 31 and an additional $9 million thereafter, leaving $30 million in the original authorization. Furthermore, the Board authorized an incremental $50 million for buybacks, bringing total remaining capacity to around $80 million. Every $10 million of buyback at $8 per share adds approximately $0.04 per share to book value, creating a direct and measurable accretive effect. This activity is particularly compelling given that book value per share was $10.92 on March 31 and is $10.95 pro forma for post-March buybacks, indicating that the repurchases are already enhancing intrinsic value. The market appears to be undervaluing NMFC’s ability to consistently generate accretive returns through disciplined capital allocation, especially as the company leverages its balance sheet strength to buy back stock at deep discounts while maintaining ample liquidity for opportunistic investments. The combination of reduced share count and rising book value per share supports a sustainable path to NAV accretion that is not fully reflected in the current stock price.
NMFC’s investment in distressed or misunderstood assets presents a powerful, underappreciated catalyst for future NAV growth, particularly through secondary market purchases and turnaround opportunities in legacy equity holdings. During Q1 FY26, the company acquired a loan in a multibillion-dollar public company at just 2x EBITDA and $0.65 on the dollar, which rapidly traded up approximately 10 points post-purchase, demonstrating the efficacy of its contrarian approach. Management highlighted similar opportunities in the secondary market where they believe they have a “differentiated view” and the potential for “meaningful book value upside if our thesis proves correct.” Additionally, NMFC holds equity positions in companies like Benevis, UniTek, and Permian that have faced past challenges but are now showing forward momentum. UniTek, in particular, is positioned to benefit from the broadband build-out and data center expansion, with a backlog of projects tied to both public and private funding. Benevis, a dental business, has seen improving operational metrics under new leadership and is expected to come off nonaccrual as its capital structure is restructured. These assets are not merely being held for recovery; they are active sources of future upside through either improved operating performance or strategic monetization in a strengthening M&A environment. The market may be underestimating the probability and timing of these equity stakes transitioning from non-income-producing to value-generating assets, especially as NMFC plans to redeploy proceeds into higher-yielding, cash-producing loans.
The company’s evolving liability structure and asset mix position it to benefit disproportionately from a widening spread environment and rising interest rates, creating a structural tailwind that is not yet priced into the stock. As of March 31, NMFC’s loan portfolio was 89% floating rate, while liabilities were 73% floating rate, with the company actively working to match these percentages to reduce interest rate sensitivity. Management noted that the shift from 50% floating rate liabilities a year ago to the current 73% has already alleviated pressure from potential base rate decreases, and the ongoing evolution of this mix will further stabilize earnings in a volatile rate environment. More importantly, the CFO and COO indicated that general market spreads have widened by 25 to 50 basis points, with even broader widening in the software sector, allowing NMFC to deploy capital into new loans at significantly higher and more attractive yields than existed 12 months ago. The portfolio yield increased to 11.1% in Q1 FY26, driven by higher-yielding originations and the repositioning of the portfolio toward assets with better risk-adjusted returns. This shift is not temporary; it reflects a deliberate strategy to capitalize on market dislocations, and as spreads remain wide or widen further, NMFC’s net interest margin is poised to expand, directly boosting net investment income and dividend coverage. The market may be overlooking the durability of this earnings tailwind, assuming it is cyclical when in fact it is driven by structural changes in the company’s asset and liability composition.
NMFC’s disciplined risk management and improving credit metrics offer a foundation for stable, growing income that contrasts with market perceptions of heightened risk in the BDC sector. Despite broader market volatility, 91% of the portfolio remains rated green on the internal risk scale, with orange and red-rated assets constituting only 3.5% of fair value. Nonaccruals at fair value stood at 2.6% for the quarter, a modest increase, and management emphasized that the primary driver of NAV decline was broader market movement (accounting for two-thirds of the decline), not credit deterioration. Specific challenged names like Affordable Care and Convey are expected to exit nonaccrual status in coming quarters due to active restructuring efforts, including a change in control for Affordable Care that will reduce its debt burden and increase financial flexibility. The company has a track record of reversing unrealized losses, having realized only $56 million in net losses over approximately $10.5 billion of investments since its IPO. Furthermore, 98% of investment income is recurring, and 83% is paid in cash, underscoring the quality and sustainability of earnings. The market may be conflating NMFC with higher-risk peers in the private credit space, failing to recognize its conservative underwriting, low loss history, and proactive management of problem assets—factors that support a more resilient and predictable income stream than currently assumed.
NMFC’s reliance on share buybacks as a primary driver of value creation raises concerns about the sustainability and opportunity cost of capital allocation, particularly when compared to reinvesting in higher-yielding, credit-enhancing opportunities. While management highlighted the accretive effect of buying back stock at $8 per share—a 27% discount to book value—the practice of deploying capital into repurchases rather than new originations may limit long-term earnings growth. The company exhausted $66 million of its buyback authorization in Q1 FY26 and has $80 million remaining, but every dollar used for buybacks is a dollar not invested in new loans yielding over 11%, especially as management noted they are deploying capital into new loans at “significantly higher and more attractive yields” than a year ago. Furthermore, the benefit of buybacks is contingent on the stock remaining undervalued; if the market rerates the stock closer to intrinsic value, the accretive effect diminishes. There is also a risk that aggressive buybacks could signal a lack of compelling internal investment opportunities, potentially undermining investor confidence in the company’s growth trajectory. The focus on buybacks may also distract from the need to reinvest proceeds from the $470 million portfolio sale into assets that generate recurring cash income, rather than simply reducing share count—a tactic that, while accretive to book value per share, does not directly increase absolute earnings power unless paired with productive reinvestment.
The turnaround potential in NMFC’s legacy equity holdings, such as Benevis, UniTek, and Permian, remains highly uncertain and may be overstated, given the historical challenges these businesses have faced and the extended timelines required for operational improvement. Management expressed confidence in UniTek’s position due to broadband and data center tailwinds, but did not provide specific metrics on revenue growth, contract wins, or margin expansion to substantiate the claim that the business is “executing well.” Similarly, while Benevis is expected to come off nonaccrual due to a change in capital structure, there was no discussion of whether the underlying dental business is achieving sustainable same-store sales growth or improving patient retention—factors critical to long-term viability in a competitive, insurance-driven market. The company acknowledged that Affordable Care is undergoing restructuring and that North Star is in liquidation, with cash recovery not expected until next year, highlighting the illiquid and uncertain nature of these workout scenarios. The market may be rewarding NMFC for optimism around these assets, but the reality is that turning around underperforming portfolio companies requires significant time, operational expertise, and favorable external conditions—none of which were quantified in the call. Until these equity stakes demonstrate clear, measurable progress toward profitability or a defined exit path, they remain a drag on ROE and a source of potential write-downs rather than value creators.
NMFC’s exposure to sector-specific volatility, particularly in software and healthcare, poses a hidden risk that could undermine portfolio performance despite the company’s claims of diversification and defensive positioning. While management emphasized that 91% of the portfolio is green-rated and that only 3.5% is in orange or red categories, they also acknowledged that the software sector is experiencing “broader spread widening” and increased pricing dispersion, with yields potentially ranging from 550 to 1,000 basis points over SOFR—a wide spread reflecting divergent views on business model quality. This dispersion increases the risk of mispricing and potential downgrades if the market’s assessment of certain software borrowers deteriorates further. Additionally, although the company reduced its software exposure as part of its strategic pivot, it did not disclose the exact percentage of the portfolio still allocated to software, leaving investors to infer residual risk. In healthcare, the company holds positions in subsectors like dental (Benevis) and specialty care (Affordable Care), which are sensitive to reimbursement changes, labor costs, and consumer discretionary trends. The fact that Affordable Care was moved to nonaccrual due to operational challenges in some business units, and that Converse required new leadership recruitment, suggests that even within supposedly defensive sectors, company-specific risks can emerge. The market may be underestimating how idiosyncratic failures in these niches could cascade, particularly if macroeconomic pressures such as wage inflation or reimbursement cuts intensify.
The sustainability of NMFC’s high dividend yield—currently approximately 12% annualized based on the $0.25 quarterly payout—is questionable given the pressure on net investment income and the reliance on non-recurring items to maintain coverage. Although management stated that the dividend is “more than covered by earnings from our core business,” the adjusted net investment income for Q1 FY26 was exactly $0.32 per share, matching the dividend paid, leaving little margin for error. This coverage was supported by a “full voluntary incentive fee waiver of $6.1 million,” which is not a permanent feature of earnings and may not persist if the company’s performance improves or if the board decides to reinstate fees. Furthermore, total investment income decreased 11% quarter-over-quarter to $69 million, and while net expenses declined 18%, the core earnings power appears fragile without the benefit of one-time adjustments. The company also noted that only 3% of investment income is driven by modified PIK from amendments or restructuring, but a larger portion may still be tied to income that is not fully cash-sustainable. If the portfolio continues to experience mark-to-market pressure or if credit-related migration increases, the buffer between net investment income and the dividend could erode quickly. The market may be accepting the high yield at face value without scrutinizing the quality and consistency of the underlying income stream, particularly in an environment where spread widening may not translate immediately into higher accrual income due to lag in portfolio repricing.
NMFC’s reliance on share buybacks as a primary driver of value creation raises concerns about the sustainability and opportunity cost of capital allocation, particularly when compared to reinvesting in higher-yielding, credit-enhancing opportunities. While management highlighted the accretive effect of buying back stock at $8 per share—a 27% discount to book value—the practice of deploying capital into repurchases rather than new originations may limit long-term earnings growth. The company exhausted $66 million of its buyback authorization in Q1 FY26 and has $80 million remaining, but every dollar used for buybacks is a dollar not invested in new loans yielding over 11%, especially as management noted they are deploying capital into new loans at “significantly higher and more attractive yields” than a year ago. Furthermore, the benefit of buybacks is contingent on the stock remaining undervalued; if the market rerates the stock closer to intrinsic value, the accretive effect diminishes. There is also a risk that aggressive buybacks could signal a lack of compelling internal investment opportunities, potentially undermining investor confidence in the company’s growth trajectory. The focus on buybacks may also distract from the need to reinvest proceeds from the $470 million portfolio sale into assets that generate recurring cash income, rather than simply reducing share count—a tactic that, while accretive to book value per share, does not directly increase absolute earnings power unless paired with productive reinvestment.
The turnaround potential in NMFC’s legacy equity holdings, such as Benevis, UniTek, and Permian, remains highly uncertain and may be overstated, given the historical challenges these businesses have faced and the extended timelines required for operational improvement. Management expressed confidence in UniTek’s position due to broadband and data center tailwinds, but did not provide specific metrics on revenue growth, contract wins, or margin expansion to substantiate the claim that the business is “executing well.” Similarly, while Benevis is expected to come off nonaccrual due to a change in capital structure, there was no discussion of whether the underlying dental business is achieving sustainable same-store sales growth or improving patient retention—factors critical to long-term viability in a competitive, insurance-driven market. The company acknowledged that Affordable Care is undergoing restructuring and that North Star is in liquidation, with cash recovery not expected until next year, highlighting the illiquid and uncertain nature of these workout scenarios. The market may be rewarding NMFC for optimism around these assets, but the reality is that turning around underperforming portfolio companies requires significant time, operational expertise, and favorable external conditions—none of which were quantified in the call. Until these equity stakes demonstrate clear, measurable progress toward profitability or a defined exit path, they remain a drag on ROE and a source of potential write-downs rather than value creators.
NMFC’s exposure to sector-specific volatility, particularly in software and healthcare, poses a hidden risk that could undermine portfolio performance despite the company’s claims of diversification and defensive positioning. While management emphasized that 91% of the portfolio is green-rated and that only 3.5% is in orange or red categories, they also acknowledged that the software sector is experiencing “broader spread widening” and increased pricing dispersion, with yields potentially ranging from 550 to 1,000 basis points over SOFR—a wide spread reflecting divergent views on business model quality. This dispersion increases the risk of mispricing and potential downgrades if the market’s assessment of certain software borrowers deteriorates further. Additionally, although the company reduced its software exposure as part of its strategic pivot, it did not disclose the exact percentage of the portfolio still allocated to software, leaving investors to infer residual risk. In healthcare, the company holds positions in subsectors like dental (Benevis) and specialty care (Affordable Care), which are sensitive to reimbursement changes, labor costs, and consumer discretionary trends. The fact that Affordable Care was moved to nonaccrual due to operational challenges in some business units, and that Converse required new leadership recruitment, suggests that even within supposedly defensive sectors, company-specific risks can emerge. The market may be underestimating how idiosyncratic failures in these niches could cascade, particularly if macroeconomic pressures such as wage inflation or reimbursement cuts intensify.
The sustainability of NMFC’s high dividend yield—currently approximately 12% annualized based on the $0.25 quarterly payout—is questionable given the pressure on net investment income and the reliance on non-recurring items to maintain coverage. Although management stated that the dividend is “more than covered by earnings from our core business,” the adjusted net investment income for Q1 FY26 was exactly $0.32 per share, matching the dividend paid, leaving little margin for error. This coverage was supported by a “full voluntary incentive fee waiver of $6.1 million,” which is not a permanent feature of earnings and may not persist if the company’s performance improves or if the board decides to reinstate fees. Furthermore, total investment income decreased 11% quarter-over-quarter to $69 million, and while net expenses declined 18%, the core earnings power appears fragile without the benefit of one-time adjustments. The company also noted that only 3% of investment income is driven by modified PIK from amendments or restructuring, but a larger portion may still be tied to income that is not fully cash-sustainable. If the portfolio continues to experience mark-to-market pressure or if credit-related migration increases, the buffer between net investment income and the dividend could erode quickly. The market may be accepting the high yield at face value without scrutinizing the quality and consistency of the underlying income stream, particularly in an environment where spread widening may not translate immediately into higher accrual income due to lag in portfolio repricing.